Xie Tian T - OmicsDI

Show results for

Unknown (612)
Proteomics (38)
Metabolomics (3)
Genomics (2)
Transcriptomics (1)

Organisms

Schizophyllum commune H4-8 (23)
Mycobacterium tuberculosis SP7 (23)
Salmonella enterica subsp. enterica serovar Typhimurium str. T000240 (23)
Oryza sativa Japonica Group (23)
Crotalus durissus terrificus (23)
Eriocheir sinensis (23)
Candidatus Endoriftia persephonae (23)
Mycobacterium tuberculosis SP10 (23)
Mycobacterium tuberculosis SP13 (23)
Cotesia typhae (23)
Mycobacterium tuberculosis SP22 (23)
Cepaea nemoralis (23)
Enterobacter ludwigii (23)
Trichoderma asperellum CBS 433.97 (23)
Corynebacterium diphtheriae bv. mitis str. ISS 3319 (23)
Nakaseomyces glabratus (23)
Olea europaea (23)
Chlamydomonas reinhardtii (23)
Lama (23)
Planorbella pilsbryi (23)
Wolbachia sp. wMelPop (23)
Pyricularia oryzae P131 (23)
Enterococcus mundtii CRL35 (23)
Pongo pygmaeus (23)
Mus musculus (7)
Homo sapiens (7)
Arabidopsis thaliana (1)
Elaphe taeniura (1)
Oryza sativa (1)
Oryctolagus cuniculus (1)

Repository

pride (23)
iProX (14)
MetaboLights (3)
biostudies-arrayexpress (2)
EGA (1)
MassIVE (1)

Tissue

Liver (4)
Smooth muscle cell (3)
Cell culture (3)
Blood serum (2)
Hepatocyte (2)
Sensory ganglion (1)
Adenohypophysis (1)
Thyroid nodule (1)
Pericarp (1)
Neuron (1)
HeLa cell (1)
Blood cell (1)
Plant cell (1)
Testis (1)
Blood plasma (1)
Whole body (1)

Disease

Hepatocellular carcinoma (2)
Rheumatoid arthritis (2)
Neuropathic pain (1)
Thyroid cancer (1)
Liver cancer (1)
Severe acute respiratory syndrome (1)
Cardiovascular system disease (1)
Disease free (1)

Technology Type

Mass Spectrometry (23)
Shotgun proteomics (12)
Bottom-up proteomics (5)
Mass spectrometry (3)
Gel-based experiment (2)
SRM/MRM (2)
Data-dependent acquisition (2)
SWATH MS (2)
DiaPASEF (1)
Data-independent acquisition (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (3)
Liquid Chromatography MS - positive - reverse phase (3)
Orbitrap Fusion Lumos (1)

Publication Date

2025 (8)
2022 (8)
2021 (5)
2019 (4)
2026 (3)
2023 (3)
2024 (2)
2015 (1)
2011 (1)
2020 (1)
2018 (1)

CHEBI ID

CHEBI:167730 (2)
CHEBI:77936 (2)
CHEBI:167858 (2)
CHEBI:28157 (2)
CHEBI:10353 (2)
CHEBI:27794 (2)
CHEBI:17211 (2)
CHEBI:42223 (2)
CHEBI:59948 (2)
CHEBI:490095 (2)
CHEBI:28499 (2)
CHEBI:36090 (2)
CHEBI:16112 (2)
CHEBI:3908 (2)
CHEBI:42025 (2)
CHEBI:9055 (2)
CHEBI:36773 (2)
CHEBI:30754 (2)
CHEBI:28281 (2)
CHEBI:27432 (2)
CHEBI:18388 (2)
CHEBI:17488 (2)
CHEBI:29864 (2)
CHEBI:16243 (2)
CHEBI:9300 (2)
CHEBI:17276 (2)
CHEBI:28197 (2)
CHEBI:133094 (2)
CHEBI:17154 (2)
CHEBI:68329 (2)

Metabolite Name

Columbianetin (2)
Kaempferol (2)
Scoparone (2)
Acetophenone (2)
Genistein (2)
Piceatannol (2)
Quercetin (2)
Phloretin (2)
Daidzein (2)
Hesperetin (2)
Caffeine (2)
Hypoxanthine (2)
Guanine (2)
Phloroglucinol (2)
Nicotinamide (2)
Adenosine (2)
3-acetyl-11-keto-beta-boswellic acid (1)
3-methyl-2-oxindole (1)
2-trans-hexadecenoic acid (1)
Rac-glycerol 1-myristate (1)
Methyl 2-hydroxy-4-{3-[(4-oxo-3-phenyl-4h-chromen-7-yl)oxy]propoxy}-3-propylbenzoate (1)
Palmitelaidic acid methyl ester (1)
5-hydroxy-3-(hydroxymethyl)-6-isopropyl-2-oxo-3-cyclohexen-1-yl 3-methylpentanoate (1)
N-[2-(trifluoromethyl)phenyl]pyrrolidine-1-carbothioamide (1)
7-hydroxytestosterone (1)
4-(methylthio) aniline (1)
Methyl 4-(aminocarbonyl)-n-cyanotetrahydropyridine-1(2H)-carbimidothioate (1)
Alpha-pinene-2-oxide (1)
Ethyl 3-[2-(diphenylmethylidene)hydrazino]but-2-enoate (1)
N-[3-(aminosulfonyl)phenyl]-2-phenoxynicotinamide (1)

Study type

Transcription profiling by array (1)
Methylation profiling by high throughput sequencing (1)

Release Date

2025 (107)
2024 (96)
2022 (92)
2023 (65)
2021 (56)
2020 (56)
2019 (33)
2015 (26)
2018 (20)
2017 (17)
2016 (15)
2026 (12)
2014 (6)
2013 (4)
2011 (2)
2012 (2)
2009 (2)
2010 (1)
2008 (1)
2001 (1)

Lab affiliation

Medical Basic Research Innovation Center for Cardiovascular and Cerebrovascular Diseases, Ministry of Education, Nanjing Medical University, Nanjing, Jiangsu, China (3)
Department of Laboratory Animals, College of Animal Sciences, Jilin University, Changchun 130062, Jilin, P.R. China (1)
Department of Rheumatology and immunology, Second Xiangya Hospital of South Central University, No.139 Ren Min Department of Rheumatology and immunology, Second Xiangya Hospital of South Central University, No.139 Ren Min Middle Road, Chang Sha,China41001111111rtment of Rheumatology and immunology, Second Xiangya Hospital of South Central University, No.139 Ren Min Mid6969Chang Sha,China410011d, Chang Sha,China410011 (1)
MOE Laboratory of Biosystem Homeostasis and Protection, College of Life Sciences, Zhejiang University; Hangzhou, Zhejiang, 310058, China (1)
School of Biological Sciences, The University of Hong Kong (1)
Doctor at Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China (1)
Department of Rheumatology and immunology, Second Xiangya Hospital of Central South University, No.139 Ren Min Middle Road (1)
School of Medicine, School of Life Sciences, Westlake University, Hangzhou, Zhejiang, China. (1)
State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical Engineering, Chemistry and Biomedicine Innovation Center (ChemBIC), Nanjing University, Nanjing, China (1)
Department of Neurosurgery, Suzhou Kowloon Hospital, Shanghai Jiaotong University School of Medicine, 118 Wanshen Street, Suzhou, China. (1)
School of Life Sciences, Westlake University, Hangzhou, Zhejiang Province, China (1)
Chongqing University (1)
State Key Laboratory of Proteomics, National Center for Protein Sciences Beijing, 38 Life Science Park Road, Beijing 102206, P.R. China (1)
Department of Cell Biology and Molecular Medicine, Rutgers New Jersey Medical School, Rutgers Biomedical and Health Sciences (1)
Third Military Medical University (1)
State Key Laboratory of Proteomics, National Center for Protein Sciences Beijing, 38 Life Science Park Road, Beijing 102206, P.R. China. (1)
Nanjing Med Univ, State Key Lab Reprod Med, Dept Histol & Embryol, 140 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China. (1)
Westlake University (1)
Chongqing Medical University (1)
Tongji University (1)
1 Affiliated Hangzhou First People’s Hospital, State Key Laboratory of Medical Proteomics, School of Medicine, School of Future Biomedicine, Westlake University, Hangzhou, Zhejiang Province, China. 2 Westlake Center for Intelligent Proteomics, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang Province, China. 3 Research Center for Industries of the Future, School of Life Sciences, Westlake University, Hangzhou, Zhejiang Province, China. (1)

Previous page
1 / 66
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 66
Next page

Sort by:

Relevance

Page size

Chinese Herbal Prescription Fu-Zheng-Qu-Xie Prevents Recurrence and Metastasis of Postoperative Early-Stage Lung Adenocarcinoma: A Prospective Cohort Study Followed with Potential Mechanism Exploration.

Not available

S-EPMC8133853 | biostudies-literature

Tomato fruit ripening Phosphoproteome

Through the quantitative proteomics research strategy of TMT labeling and phosphorylation enrichment technology and high-resolution liquid chromatography-mass spectrometry, this project carried out the quantitative research of phosphorylated proteomics. In this study, a total of 6227 phosphorylation...

ORGANISM(S): Solanum lycopersicum

2022-02-17 | PXD027844 | Pride

Protocol to investigate the biochemical details of immune checkpoint ligand/receptor ubiquitination using in vitro ubiquitination assay.

Not available

S-EPMC12554173 | biostudies-literature

N-glycoproteomics and SESTAR++ analysis based on SeMOE

The isotopic envelope pattern of selenium is guaranteed by its six stable isotopes with distinctive distribution (74Se, 0.89%; 76Se, 9.37%; 77Se, 7.63%; 78Se, 23.77%; 80Se, 49.61%; 82Se, 8.73%). We postulated that the effective incorporation of selenosugar in glycoproteins would achieve direct isoto...

ORGANISM(S): Homo sapiens (Human)

2023-11-20 | PXD042137 | Pride

Human N-glycoproteomics Hela cell Sestar Semoe

Association of COL1A1 polymorphisms with osteoporosis: a meta-analysis of clinical studies.

Not available

S-EPMC4658848 | biostudies-literature

Absence of TSC1 Accelerates CD8⁺ T cell-mediated Acute Cardiac Allograft Rejection.

Not available

S-EPMC9466980 | biostudies-literature

<i>Moringa oleifera</i> leaves protein suppresses T-lymphoblastic leukemogenesis via MAPK/AKT signaling modulation of apoptotic activation and autophagic flux regulation.

Not available

S-EPMC11996636 | biostudies-literature